Kohesio: discover EU projects in your region

project info
Start date: 1 January 2021
End date: 30 November 2023
funding
Fund: European Regional Development Fund (ERDF)
Total budget: 109 638,36 €
EU contribution: 65 783,02 € (60%)
programme
Programming period: 2014-2020
Managing authority: Ministerstwo obsługujące ministra właściwego ds. rozwoju regionalnego
European Commission Topic

Promotion Onko BCG – a drug used to treat superficial, epithelial, non-invasive bladder tumors in foreign markets

SA 42799(2015/X) The object of this project is to undertake actions aimed at increasing the recognition of the Onko BCG product on foreign markets. As part of the project, the Applicant will carry out promotional activities as part of the Biotechnology and Pharmaceutical Promotion Programme, including in the following forward-looking markets: USA, UAE, Saudi Arabia and Turkey. The applicant planned to participate in trade fairs: — Bio International Convention 2021, USA – CPHI Worldwide 2021, Europe – CPHI Middle East and Africa 2021, UAE – CPHI North America 2021, USA The applicant also planned outward economic missions to countries: 1. Germany-Drezno. Q2/Q3 2021 2. Turkey- Istanbul. Estimated date of the mission: Q1/Q2 2021 3. Saudi Arabia- Riyadh. Estimated date of the mission: Q2/Q3 2021 Each mission will be attended by 2 people from Biomed Lublin. Promotional materials will be prepared, such as: preparation of panels promoting MPG for each trade fair, preparation of marketing materials for each fair, which will provide the products with appropriate exposure and binding, as well as facilitate their promotion in selected foreign markets, helpful in presenting themselves at fairs and meetings. The implementation of the project will be financed from the company’s own capital and revenue generated on an ongoing basis. During the implementation of the project, it is also planned to use the pre-financing form.

Flag of Poland  Lubelski, Poland